Latest news with #DeepYellowLimited
Business Insider
18-06-2025
- Business
- Business Insider
Morgans Reaffirms Their Buy Rating on Deep Yellow Limited (DYLLF)
In a report released today, Ross Bennett from Morgans maintained a Buy rating on Deep Yellow Limited (DYLLF – Research Report), with a price target of A$1.92. The company's shares closed today at $1.05. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Bennett covers the Basic Materials sector, focusing on stocks such as Regis Resources Limited, Turaco Gold Ltd, and Northern Star Resources Ltd. According to TipRanks, Bennett has an average return of 43.2% and a 100.00% success rate on recommended stocks. Currently, the analyst consensus on Deep Yellow Limited is a Strong Buy with an average price target of $0.95.
Yahoo
13-05-2025
- Business
- Yahoo
ASX Penny Stock Highlights For May 2025
The ASX200 is set to open 1.18% higher, reflecting optimism following a temporary tariff cut agreement between China and the United States at a Geneva summit. In light of these market conditions, identifying stocks with strong financials becomes crucial, especially when considering the potential of smaller or newer companies. Penny stocks, although an older term, continue to offer intriguing opportunities for investors seeking affordable entry points with growth potential. Name Share Price Market Cap Financial Health Rating CTI Logistics (ASX:CLX) A$1.75 A$140.95M ★★★★☆☆ Accent Group (ASX:AX1) A$1.925 A$1.09B ★★★★☆☆ EZZ Life Science Holdings (ASX:EZZ) A$1.45 A$68.4M ★★★★★★ IVE Group (ASX:IGL) A$2.70 A$416.29M ★★★★★☆ GTN (ASX:GTN) A$0.665 A$127.1M ★★★★★★ West African Resources (ASX:WAF) A$2.42 A$2.76B ★★★★★★ GR Engineering Services (ASX:GNG) A$2.80 A$468.59M ★★★★★★ Bisalloy Steel Group (ASX:BIS) A$3.35 A$158.96M ★★★★★★ Regal Partners (ASX:RPL) A$2.30 A$773.18M ★★★★★★ NRW Holdings (ASX:NWH) A$2.83 A$1.29B ★★★★★☆ Click here to see the full list of 993 stocks from our ASX Penny Stocks screener. Let's explore several standout options from the results in the screener. Simply Wall St Financial Health Rating: ★★★★★☆ Overview: Aussie Broadband Limited offers telecommunications and technology services in Australia, with a market cap of A$1.20 billion. Operations: The company's revenue is derived from its Residential segment (A$628.51 million), Wholesale segment (A$143.55 million), Business segment (A$102.99 million), and Enterprise and Government segment (A$93.51 million). Market Cap: A$1.2B Aussie Broadband, with a market cap of A$1.20 billion, is experiencing growth in its earnings and revenue, supported by strong cash flow that covers its debt well. The company has shown improved financial health over the past five years, transitioning from negative to positive shareholder equity. Recent strategic moves include seeking acquisitions to enhance business scale and capability while maintaining a satisfactory net debt to equity ratio of 7.2%. Despite low return on equity at 5%, the board's experience and recent executive changes aim to bolster governance as they pursue further M&A opportunities for growth. Navigate through the intricacies of Aussie Broadband with our comprehensive balance sheet health report here. Learn about Aussie Broadband's future growth trajectory here. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Deep Yellow Limited, with a market cap of A$1.31 billion, is a uranium exploration company operating in Namibia and Australia through its subsidiaries. Operations: Deep Yellow Limited does not report any revenue segments. Market Cap: A$1.31B Deep Yellow Limited, with a market cap of A$1.31 billion, operates as a pre-revenue uranium exploration company. Despite reporting A$6.29 million in revenue for the half-year ended December 2024, it remains unprofitable with net losses narrowing to A$2.47 million from A$6.19 million a year prior. The company benefits from being debt-free and having short-term assets of A$246.1 million that cover both its short- and long-term liabilities comfortably. While earnings are projected to decline significantly over the next three years, Deep Yellow maintains a stable cash runway exceeding three years based on current free cash flow trends. Click here and access our complete financial health analysis report to understand the dynamics of Deep Yellow. Understand Deep Yellow's earnings outlook by examining our growth report. Simply Wall St Financial Health Rating: ★★★★★★ Overview: IGO Limited is an exploration and mining company in Australia that focuses on discovering, developing, and operating assets for metals essential to clean energy, with a market cap of A$3.30 billion. Operations: The company's revenue is primarily generated from its Nova Operation, which contributes A$460.8 million, and the Forrestania Operation, adding A$153 million. Market Cap: A$3.3B IGO Limited, with a market cap of A$3.30 billion, operates in the metals and mining sector focusing on clean energy assets. Despite generating significant revenue from its Nova and Forrestania operations, recent financial results show a net loss of A$782.1 million for the half-year ended December 31, 2024. The company is debt-free, with short-term assets of A$437.5 million exceeding both short- and long-term liabilities comfortably. Management changes are underway as key executives plan to depart by year-end 2025. Although IGO's earnings are forecasted to grow substantially per analyst estimates, current unprofitability remains a challenge for investors considering penny stocks in this sector. Jump into the full analysis health report here for a deeper understanding of IGO. Gain insights into IGO's outlook and expected performance with our report on the company's earnings estimates. Navigate through the entire inventory of 993 ASX Penny Stocks here. Ready For A Different Approach? Outshine the giants: these 28 early-stage AI stocks could fund your retirement. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ASX:ABB ASX:DYL and ASX:IGO. This article was originally published by Simply Wall St. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
14-04-2025
- Business
- Yahoo
Clarity Pharmaceuticals And 2 Other ASX Penny Stocks To Watch
The Australian market saw a positive start to the week, with sectors like IT and Materials leading gains, buoyed by rising iron ore and gold prices. In this context, penny stocks—though an outdated term—remain a relevant investment area for those interested in smaller or newer companies. By focusing on stocks with strong financial health and growth potential, investors can uncover opportunities that might offer both stability and upside. Name Share Price Market Cap Financial Health Rating CTI Logistics (ASX:CLX) A$1.565 A$122.09M ★★★★☆☆ MotorCycle Holdings (ASX:MTO) A$2.07 A$152.78M ★★★★★★ Accent Group (ASX:AX1) A$1.815 A$1.03B ★★★★☆☆ EZZ Life Science Holdings (ASX:EZZ) A$1.45 A$68.4M ★★★★★★ IVE Group (ASX:IGL) A$2.42 A$373.12M ★★★★★☆ GTN (ASX:GTN) A$0.62 A$119.24M ★★★★★★ Bisalloy Steel Group (ASX:BIS) A$3.21 A$152.31M ★★★★★★ Regal Partners (ASX:RPL) A$1.94 A$652.16M ★★★★★★ Southern Cross Electrical Engineering (ASX:SXE) A$1.715 A$453.22M ★★★★★★ NRW Holdings (ASX:NWH) A$2.39 A$1.09B ★★★★★☆ Click here to see the full list of 982 stocks from our ASX Penny Stocks screener. Here's a peek at a few of the choices from the screener. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Clarity Pharmaceuticals Ltd is a clinical stage radiopharmaceutical company focused on research and development of radiopharmaceutical products in Australia and the United States, with a market cap of A$560.76 million. Operations: The company generates revenue primarily from its Radiopharmaceutical Development segment, amounting to A$10.78 million. Market Cap: A$560.76M Clarity Pharmaceuticals, with a market cap of A$560.76 million, is advancing its clinical stage radiopharmaceuticals, focusing on prostate cancer treatments. Recent milestones include the completion of the Dose Escalation Phase in the SECuRE trial and multiple Fast Track Designations from the FDA for its Cu-SAR-bisPSMA product. Despite being unprofitable and reporting a net loss of A$23.58 million for the half-year ending December 2024, Clarity maintains strong short-term assets (A$136.5 million) against liabilities and has no debt. The company's strategic focus on addressing unmet needs in prostate cancer could position it well within this niche market segment. Click to explore a detailed breakdown of our findings in Clarity Pharmaceuticals' financial health report. Understand Clarity Pharmaceuticals' earnings outlook by examining our growth report. Simply Wall St Financial Health Rating: ★★★★★★ Overview: Deep Yellow Limited is a uranium exploration company operating in Namibia and Australia, with a market cap of A$919.07 million. Operations: Deep Yellow Limited has not reported any specific revenue segments. Market Cap: A$919.07M Deep Yellow Limited, with a market cap of A$919.07 million, is focused on uranium exploration in Namibia and Australia. Despite being pre-revenue with less than US$1 million in revenue, the company reported an improved net loss of A$2.47 million for the half-year ending December 2024 compared to A$6.19 million a year ago. The firm remains debt-free and has robust short-term assets (A$246.1M) exceeding its liabilities, providing financial stability amidst volatility (10%). Recent initiatives include a share buyback program aimed at reducing outstanding shares slightly and potentially enhancing shareholder value over time. Click here to discover the nuances of Deep Yellow with our detailed analytical financial health report. Evaluate Deep Yellow's prospects by accessing our earnings growth report. Simply Wall St Financial Health Rating: ★★★★☆☆ Overview: Stanmore Resources Limited is involved in the exploration, development, production, and sale of metallurgical coal in Australia with a market cap of A$1.60 billion. Operations: The company generates revenue of $2.40 billion from its metals and mining segment, specifically through coal operations. Market Cap: A$1.6B Stanmore Resources, with a market cap of A$1.60 billion, reported 2024 revenue of US$2.50 billion, down from US$2.81 billion the previous year, reflecting challenges in earnings growth and profitability as net income fell to US$191.5 million from US$472.4 million. The company's debt is well-covered by operating cash flow at 132%, but short-term assets do not cover long-term liabilities of US$806.2 million, indicating potential financial pressure despite satisfactory net debt to equity ratio (1%). Recent dividend decreases highlight sustainability concerns as dividends aren't covered by free cash flows while trading below fair value suggests investment potential amidst volatility and management stability concerns due to an inexperienced board. Dive into the specifics of Stanmore Resources here with our thorough balance sheet health report. Examine Stanmore Resources' earnings growth report to understand how analysts expect it to perform. Gain an insight into the universe of 982 ASX Penny Stocks by clicking here. Contemplating Other Strategies? Rare earth metals are an input to most high-tech devices, military and defence systems and electric vehicles. The global race is on to secure supply of these critical minerals. Beat the pack to uncover the 21 best rare earth metal stocks of the very few that mine this essential strategic resource. This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Companies discussed in this article include ASX:CU6 ASX:DYL and ASX:SMR. Have feedback on this article? Concerned about the content? with us directly. Alternatively, email editorial-team@ Sign in to access your portfolio
